See All Slides - tctmd.com

Slides

Presentation TCT 2012

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Presenter: Blase Carabello

October 22, 2012

Presentation TCT 2012

Case Presentation with Discussion(8)

Presenter: Ariel Duran

October 22, 2012

Presentation TCT 2012

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Presenter: Alessandro Bortone

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Two Complex Non-Left Main Bifurcation Cases: My Solutions

Presenter: Jean Fajadet

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TCT 2012

Hemodynamics of the Normal Heart from the Technologist's Perspective

Presenter: Sally Elliott

October 22, 2012

Presentation TCT 2012

Current Landscape: One-Year Post-Initial FDA Approval

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Bone Marrow Cell Transfer for STEMI: The BAMI Program Progress Report

Presenter: Andreas Zeiher

October 22, 2012

Presentation TCT 2012

Informed Consent

Presenter: Lauren Privitera

October 22, 2012

Advertisement

Slides

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Case Presentation with Discussion(8)

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Two Complex Non-Left Main Bifurcation Cases: My Solutions

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Hemodynamics of the Normal Heart from the Technologist's Perspective

Current Landscape: One-Year Post-Initial FDA Approval

Bone Marrow Cell Transfer for STEMI: The BAMI Program Progress Report

Informed Consent

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content